Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide – an international collaborative study
Kayser,S., Schlenk,R.F., Lebon,D., Carre,M., Gotze,K.S., Stolzel,F., Berceanu,A., Schafer-Eckart,K., Peterlin,P., Hicheri,Y., Rahme,R., Raffoux,E., Chermat,F., Krause,S.W., Aulitzky,W.E., Rigaudeau,S., Noppeney,R., Berthon,C., Gorner,M., Jost,E., Carassou,P., Keller,U., Orvain,C., Braun,T., Saillard,C., Arar,A., Kunzmann,V., Wemeau,M., De Wit,M., Niemann,D., Bonmati,C., Schwanen,C., Abraham,J., Aljijakli,A., Haiat,S., Kramer,A., Reichle,A., Gnadler,M., Willekens,C., Spiekermann,K., Hiddemann,W., Muller-Tidow,C., Thiede,C., Rollig,C., Serve,H., Bornhauser,M., Baldus,C.D., Lengfelder,E., Fenaux,P., Platzbecker,U., Ades,L.
Revue : Haematologica -
2021 /
5
Volume : 106
Pages : 3600-3106